Cargando…
BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response
BACKGROUND: Data on the safety and efficacy of SARS-CoV-2 vaccines in immunocompromised populations are sparse. METHODS: We conducted a prospective study of 77 heart transplant (HT) recipients vaccinated with two doses of BNT162b2 vaccine and monitored for adverse events following both doses, the re...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Heart and Lung Transplantation.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058049/ https://www.ncbi.nlm.nih.gov/pubmed/34034958 http://dx.doi.org/10.1016/j.healun.2021.04.003 |